Financial reports
10-K
2023 FY
Annual report
11 Mar 24
10-Q
2023 Q3
Quarterly report
7 Nov 23
10-Q
2023 Q2
Quarterly report
7 Aug 23
10-Q
2023 Q1
Quarterly report
8 May 23
ARS
2022 FY
Annual report to shareholders
1 May 23
10-K
2022 FY
Annual report
6 Mar 23
10-Q
2022 Q3
Quarterly report
7 Nov 22
10-Q
2022 Q2
Quarterly report
8 Aug 22
10-Q
2022 Q1
Quarterly report
9 May 22
10-K
2021 FY
Annual report
28 Feb 22
Current reports
8-K
Departure of Directors or Certain Officers
18 Apr 24
8-K
Other Events
29 Mar 24
8-K
Ocular Therapeutix™ Reports Fourth Quarter and Full Year 2023 Results
11 Mar 24
8-K
Ocular Therapeutix, Inc. Announces $325.0 Million Private Placement
22 Feb 24
8-K
Other Events
25 Jan 24
8-K
Ocular TherapeutixTM Announces Pricing of Public Offering of Common Stock
14 Dec 23
8-K
Ocular Therapeutix™ Provides Third Quarter 2023 Financial Results and Corporate Update
7 Nov 23
8-K
Regulation FD Disclosure
4 Oct 23
8-K
Other Events
3 Oct 23
8-K
Other Events
13 Sep 23
Registration and prospectus
S-3ASR
Automatic shelf registration
25 Mar 24
S-8
Registration of securities for employees
11 Mar 24
S-8
Registration of securities for employees
22 Feb 24
424B5
Prospectus supplement for primary offering
14 Dec 23
424B5
Prospectus supplement for primary offering
13 Dec 23
S-3
Shelf registration
7 Nov 23
S-8
Registration of securities for employees
7 Aug 23
S-8
Registration of securities for employees
6 Mar 23
S-8
Registration of securities for employees
8 Aug 22
POS AM
Prospectus update (post-effective amendment)
28 Feb 22
Proxies
PRE 14A
Preliminary proxy
19 Apr 24
DEFA14A
Additional proxy soliciting materials
1 May 23
DEF 14A
Definitive proxy
1 May 23
DEFA14A
Additional proxy soliciting materials
2 May 22
DEF 14A
Definitive proxy
2 May 22
DEFA14A
Additional proxy soliciting materials
29 Apr 21
DEF 14A
Definitive proxy
29 Apr 21
PRE 14A
Preliminary proxy
13 Apr 21
DEFA14A
Additional proxy soliciting materials
15 Jun 20
DEFA14A
Additional proxy soliciting materials
29 Apr 20
Other
EFFECT
Notice of effectiveness
17 Nov 23
CORRESP
Correspondence with SEC
14 Nov 23
UPLOAD
Letter from SEC
13 Nov 23
EFFECT
Notice of effectiveness
11 May 22
SEC STAFF
SEC staff action: Order
11 Mar 21
SEC STAFF
SEC staff action: Order
10 Feb 21
CT ORDER
Confidential treatment order
24 Oct 19
EFFECT
Notice of effectiveness
30 Apr 19
CORRESP
Correspondence with SEC
25 Apr 19
UPLOAD
Letter from SEC
8 Apr 19
Ownership
4
Change in insider ownership
27 Feb 24
SC 13D/A
SUMMER ROAD LLC
27 Feb 24
4
Pravin Dugel
26 Feb 24
4
Sanjay Nayak
26 Feb 24
3
Pravin Dugel
26 Feb 24
3
Sanjay Nayak
26 Feb 24
SC 13G/A
Opaleye Management Inc.
14 Feb 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
4
Christopher G White
6 Feb 24
4
Philip C. Strassburger
6 Feb 24